Clinical vasospasm and delayed cerebral ischemia (DCI) are devastating complications of aneurysmal subarachnoid hemorrhage (aSAH). Several theories involving platelet activation have been postulated as potential explanations of the development of clinical vasospasm and DCI. However, the effects of dual antiplatelet therapy (DAPT; aspirin and clopidogrel) on clinical vasospasm and DCI have not been previously investigated. The objective of this study was to evaluate the effects of DAPT on clinical vasospasm and DCI in aSAH patients.
Analysis of patients treated for aSAH during the period from July 2009 to April 2014 was performed in a single-institution retrospective study. Patients were divided into 2 groups: patients who underwent stent-assisted coiling or placement of flow diverters requiring DAPT (DAPT group) and patients who underwent coiling only without DAPT (control group). The frequency of symptomatic clinical vasospasm and DCI and of hemorrhagic complications was compared between the 2 groups, utilizing univariate and multivariate logistic regression.
Of 312 aSAH patients considered for this study, 161 met the criteria for inclusion and were included in the analysis (85 patients in the DAPT group and 76 patients in the control group). The risks of clinical vasospasm (OR 0.244, CI 95% 0.097–0.615, p = 0.003) and DCI (OR 0.056, CI 95% 0.01–0.318, p = 0.001) were significantly lower in patients receiving DAPT. The rates of hemorrhagic complications associated with placement of external ventricular drains and ventriculoperitoneal shunts were similar in both groups (4% vs 2%, p = 0.9).
The use of DAPT was associated with a lower risk of clinical vasospasm and DCI in patients treated for aSAH, without an increased risk of hemorrhagic complications.
BoveAA, DeweyJD: Effects of serotonin and histamine on proximal and distal coronary vasculature in dogs: comparison with alpha-adrenergic stimulation. 52:1333–1339, 198310.1016/0002-9149(83)90597-06139953)| false
FrijnsCJ, FijnheerR, AlgraA, van MourikJA, van GijnJ, RinkelGJ: Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. 77:77–83, 200610.1136/jnnp.2005.06495616361599)| false
FronteraJA, FernandezA, SchmidtJM, ClaassenJ, WartenbergKE, BadjatiaN, : Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?40:1963–1968, 20091935962910.1161/STROKEAHA.108.544700)| false
HirashimaYNakamuraSEndoSKuwayamaNNaruseYTakakuA: Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res22:1249–12551997
HirashimaY, NakamuraS, EndoS, KuwayamaN, NaruseY, TakakuA: Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. 22:1249–1255, 199710.1023/A:10219850303319342729)| false
HirashimaYNakamuraSSuzukiMKurimotoMEndoSOgawaA: Cerebrospinal fluid tissue factor and thrombin-antithrombin III complex as indicators of tissue injury after subarachnoid hemorrhage. Stroke28:1666–16701997
IkedaK, AsakuraH, FutamiK, YamashitaJ: Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage. 41:344–350, 199710.1097/00006123-199708000-000029257301)| false
KassellNF, TornerJC, HaleyECJr, JaneJA, AdamsHP, KongableGL: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. 73:18–36, 199010.3171/jns.1990.73.1.0018)| false
LamJY, ChesebroJH, SteelePM, BadimonL, FusterV: Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. 75:243–248, 198710.1161/01.CIR.75.1.243)| false
RoosYBde HaanRJBeenenLFGroenRJAlbrechtKWVermeulenM: Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry68:337–3412000
RoosYB, de HaanRJ, BeenenLF, GroenRJ, AlbrechtKW, VermeulenM: Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. 68:337–341, 20001067521610.1136/jnnp.68.3.337)| false
VingeE, BrandtL, LjunggrenB, AnderssonKE: Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage. 19:644–647, 198810.1161/01.STR.19.5.6443363601)| false